Zevra Therapeutics, Inc.ZVRANASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor ZVRA?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor ZVRA

Key Statistics

About

kempharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (nces) to treat serious medical conditions through its proprietary and broadly applicable ligand activated therapy (lat) approach. the company utilizes its lat technology to generate improved prodrug versions of fda approved drugs in the high needs areas of pain, adhd and other cns diseases.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

CEO

Travis Mickle

kempharm.com/ →

News

BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet

globenewswire.com

OWL Deadline: OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit

prnewswire.com

A Bottom-Basement Lithium Entry Point for Investor Opportunity: Elektros Inc., a Lithium Mining Company, Advances Strategic Communications

accessnewswire.com

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

globenewswire.com

Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS

globenewswire.com

2 Electric Vehicle Stocks That Could Make You Rich

fool.com

MONDAY INVESTOR DEADLINE: Blue Owl Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

prnewswire.com

INVESTOR NOTICE: F5, Inc. (FFIV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

prnewswire.com

Where Will D-Wave Quantum Stock Be in 5 Years?

fool.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet

OWL Deadline: OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit

A Bottom-Basement Lithium Entry Point for Investor Opportunity: Elektros Inc., a Lithium Mining Company, Advances Strategic Communications

Microsoft's historic plunge: Why the company lost $357 billion in value despite strong results

Forget Tech Stocks: The Telehealth Stock That's Riding the AI Wave Better Than Big Tech

Disney Earnings Need to Show Parks and Streaming Growth

SJS Investment Boosts Ultra-Short Treasury Position by $6.39 Million

Could This Artificial Intelligence (AI) Stock Double in 2026?

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

Arons: "Extreme Growth" to Follow Rut, Top Picks in META, IBM & BA

NuScale Power Under $20: Your Last Chance to Buy?

Better Creative Tools Stock: Figma vs. Adobe

Gold, Silver Prices Dropped. Why Analysts Aren't Panicking.

Artificial Intelligence (AI) Could Deliver Another Decade of Growth. This Stock Is a Prime Candidate to Be a Winner.

Duke Energy urges Florida customers to reduce electric usage

Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS

2 Electric Vehicle Stocks That Could Make You Rich

MONDAY INVESTOR DEADLINE: Blue Owl Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

INVESTOR NOTICE: F5, Inc. (FFIV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Where Will D-Wave Quantum Stock Be in 5 Years?

Explore More

BHP backs the next wave of exploration and technology talent in its biggest Xplor intake yet

OWL Deadline: OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit

A Bottom-Basement Lithium Entry Point for Investor Opportunity: Elektros Inc., a Lithium Mining Company, Advances Strategic Communications

Microsoft's historic plunge: Why the company lost $357 billion in value despite strong results

Forget Tech Stocks: The Telehealth Stock That's Riding the AI Wave Better Than Big Tech

Disney Earnings Need to Show Parks and Streaming Growth

SJS Investment Boosts Ultra-Short Treasury Position by $6.39 Million

Could This Artificial Intelligence (AI) Stock Double in 2026?

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN

Arons: "Extreme Growth" to Follow Rut, Top Picks in META, IBM & BA

NuScale Power Under $20: Your Last Chance to Buy?

Better Creative Tools Stock: Figma vs. Adobe

Gold, Silver Prices Dropped. Why Analysts Aren't Panicking.

Artificial Intelligence (AI) Could Deliver Another Decade of Growth. This Stock Is a Prime Candidate to Be a Winner.

Duke Energy urges Florida customers to reduce electric usage

Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS

2 Electric Vehicle Stocks That Could Make You Rich

MONDAY INVESTOR DEADLINE: Blue Owl Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

INVESTOR NOTICE: F5, Inc. (FFIV) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Where Will D-Wave Quantum Stock Be in 5 Years?

Key Statistics